Cytokinetics (NASDAQ:CYTK – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a note issued to investors on Thursday,Benzinga reports. They presently have a $120.00 price target on the biopharmaceutical company’s stock. HC Wainwright’s price target would indicate a potential upside of 112.80% from the stock’s current price. Several […]

Cytokinetics (NASDAQ:CYTK – Get Free Report) announced its quarterly earnings results on Wednesday. The biopharmaceutical company reported ($1.36) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.27) by ($0.09), Briefing.com reports. The business had revenue of $0.46 million during the quarter, compared to the consensus estimate of $1.21 million. During the same […]

Katapult (NASDAQ:KPLT – Get Free Report) posted its earnings results on Wednesday. The company reported ($2.05) EPS for the quarter, RTT News reports. The business had revenue of $60.31 million for the quarter. During the same period in the prior year, the firm posted ($0.71) earnings per share. Katapult updated its Q4 2024 guidance to […]

ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report)‘s stock had its “buy” rating reiterated by HC Wainwright in a note issued to investors on Thursday, Benzinga reports. They currently have a $27.00 target price on the biopharmaceutical company’s stock. HC Wainwright’s price target points to a potential upside of 70.99% from the stock’s current price. Several […]